These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 21845806)
1. Update on low molecular weight heparins at the beginning of third millennium. Focus on reviparin. Del Bono R; Martini G; Volpi R Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):950-9. PubMed ID: 21845806 [TBL] [Abstract][Full Text] [Related]
2. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins]. Delsart D; Chambefort V; Decousus H Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082 [No Abstract] [Full Text] [Related]
3. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes. Haas S Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477 [TBL] [Abstract][Full Text] [Related]
4. Perspectives on antithrombotic agents: from unfractionated heparin to new antithrombotics. Agnelli G; Sonaglia F Haematologica; 2002 Jul; 87(7):757-70. PubMed ID: 12091128 [TBL] [Abstract][Full Text] [Related]
5. [State of the art: low-molecular-weight heparin and beyond]. Cimminiello C; Casali G; Vitali L Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):61-5. PubMed ID: 11253343 [TBL] [Abstract][Full Text] [Related]
6. The low molecular weight heparin, tinzaparin, in thrombosis and beyond. Mousa SA Cardiovasc Drug Rev; 2002; 20(3):199-216. PubMed ID: 12397367 [TBL] [Abstract][Full Text] [Related]
7. Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials. De Luca G; Marino P Am Heart J; 2007 Dec; 154(6):1085.e1-6. PubMed ID: 18035079 [TBL] [Abstract][Full Text] [Related]
9. Current status of low molecular weight heparins in clinical practice. Vidhya MR; Sathyamurthy I J Assoc Physicians India; 2000 Feb; 48(2):216-20. PubMed ID: 11229152 [No Abstract] [Full Text] [Related]
10. Venous thrombosis prophylaxis with low-molecular-weight heparin in hip and knee arthroplasty. Colwell CW Instr Course Lect; 2002; 51():487-9. PubMed ID: 12064138 [No Abstract] [Full Text] [Related]
11. Low-molecular-weight heparin in the treatment of deep venous thrombosis. Hauer KE West J Med; 1998 Oct; 169(4):240-4. PubMed ID: 9795594 [TBL] [Abstract][Full Text] [Related]
20. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group. Kakkar VV; Howes J; Sharma V; Kadziola Z Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]